Inactive/Delisted stock
Protagenic Therapeutics Stock (NASDAQ:PTIX)
Previous Close
$3.40
52W Range
$2.25 - $15.26
50D Avg
$3.26
200D Avg
$4.41
Market Cap
$3.20M
Avg Vol (3M)
$2.79M
Beta
0.37
Div Yield
-
PTIX Company Profile
Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound is PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. The company is based in New York, New York.